25 Sep by Vitaliy Dadalyan GoodRx, dismissed as a 'waste of time,' jumps into digital health fray and reaps billions with IPO GoodRx, widely known for its discounts at the point of sale for prescriptions, is looking at the value the market is providing the industry — and wants a slice.
